{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:33:53Z","timestamp":1790688833858,"version":"4.1.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,7,19]]},"DOI":"10.7759\/cureus.27001","type":"journal-article","created":{"date-parts":[[2022,7,19]],"date-time":"2022-07-19T07:10:19Z","timestamp":1658214619000},"source":"Crossref","is-referenced-by-count":7,"title":["POEMS Syndrome: A Case Report and Review of the Literature"],"prefix":"10.7759","author":[{"given":"Deepthi","family":"Kanuganti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venkata Sundarachary","family":"Nagarjunakonda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pranathi","family":"Bandarupalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vamsi Krishna","family":"Gorijala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venkata Lakshman Sai Ram","family":"Konagalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Praveen","family":"Kowtha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-07-2299","article-title":"POEMS syndrome: definitions and long-term outcome","volume":"101","author":"Dispenzieri A","year":"2003","unstructured":"Dispenzieri A, Kyle RA, Lacy MQ, et al.. POEMS syndrome: definitions and long-term outcome. Blood. 2003, 101:2496-506. 10.1182\/blood-2002-07-2299","journal-title":"Blood"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-198007000-00006","article-title":"Plasma cell dyscrasia with polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes: the POEMS syndrome. Report on two cases and a review of the literature","volume":"59","author":"Bardwick PA","year":"1980","unstructured":"Bardwick PA, Zvaifler NJ, Gill GN, Newman D, Greenway GD, Resnick DL. Plasma cell dyscrasia with polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes: the POEMS syndrome. Report on two cases and a review of the literature. Medicine (Baltimore). 1980, 59:311-22. 10.1097\/00005792-198007000-00006","journal-title":"Medicine (Baltimore)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-010-1149-0","article-title":"Clinical characteristics and long-term outcome of patients with POEMS syndrome in China","volume":"90","author":"Li J","year":"2011","unstructured":"Li J, Zhou DB, Huang Z, et al.. Clinical characteristics and long-term outcome of patients with POEMS syndrome in China. Ann Hematol. 2011, 90:819-26. 10.1007\/s00277-010-1149-0","journal-title":"Ann Hematol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/WCO.0000000000000610","article-title":"POEMS syndrome","volume":"31","author":"Keddie S","year":"2018","unstructured":"Keddie S, Lunn MP. POEMS syndrome. Curr Opin Neurol. 2018, 31:551-8. 10.1097\/WCO.0000000000000610","journal-title":"Curr Opin Neurol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25495","article-title":"POEMS syndrome: 2019 update on diagnosis, risk-stratification, and management","volume":"94","author":"Dispenzieri A","year":"2019","unstructured":"Dispenzieri A. POEMS syndrome: 2019 update on diagnosis, risk-stratification, and management. Am J Hematol. 2019, 94:812-27. 10.1002\/ajh.25495","journal-title":"Am J Hematol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-012-1455-9","article-title":"Characterization of immunoglobulin \u03bb light chain variable region (IGLV) gene and its relationship with clinical features in patients with POEMS syndrome","volume":"91","author":"Li J","year":"2012","unstructured":"Li J, Huang Z, Duan MH, et al.. Characterization of immunoglobulin \u03bb light chain variable region (IGLV) gene and its relationship with clinical features in patients with POEMS syndrome. Ann Hematol. 2012, 91:1251-5. 10.1007\/s00277-012-1455-9","journal-title":"Ann Hematol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.21285","article-title":"A novel report of cig-FISH and cytogenetics in POEMS syndrome","volume":"83","author":"Bryce AH","year":"2008","unstructured":"Bryce AH, Ketterling RP, Gertz MA, et al.. A novel report of cig-FISH and cytogenetics in POEMS syndrome. Am J Hematol. 2008, 83:840-1. 10.1002\/ajh.21285","journal-title":"Am J Hematol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.12189","article-title":"14q32 translocations and 13q14 deletions are common cytogenetic abnormalities in POEMS syndrome","volume":"91","author":"Kang WY","year":"2013","unstructured":"Kang WY, Shen KN, Duan MH, Zhang W, Cao XX, Zhou DB, Li J. 14q32 translocations and 13q14 deletions are common cytogenetic abnormalities in POEMS syndrome. Eur J Haematol. 2013, 91:490-6. 10.1111\/ejh.12189","journal-title":"Eur J Haematol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-06-362392","article-title":"The utility of plasma vascular endothelial growth factor levels in the diagnosis and follow-up of patients with POEMS syndrome","volume":"118","author":"D'Souza A","year":"2011","unstructured":"D'Souza A, Hayman SR, Buadi F, et al.. The utility of plasma vascular endothelial growth factor levels in the diagnosis and follow-up of patients with POEMS syndrome. Blood. 2011, 118:4663-5. 10.1182\/blood-2011-06-362392","journal-title":"Blood"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-018-0073-8","article-title":"Prognostic value of serum vascular endothelial growth factor and hematological responses in patients with newly-diagnosed POEMS syndrome","volume":"8","author":"Zhao H","year":"2018","unstructured":"Zhao H, Cai H, Wang C, et al.. Prognostic value of serum vascular endothelial growth factor and hematological responses in patients with newly-diagnosed POEMS syndrome. Blood Cancer J. 2018, 8:37. 10.1038\/s41408-018-0073-8","journal-title":"Blood Cancer J"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12236","article-title":"New advances in the diagnosis and treatment of POEMS syndrome","volume":"161","author":"Li J","year":"2013","unstructured":"Li J, Zhou DB. New advances in the diagnosis and treatment of POEMS syndrome. Br J Haematol. 2013, 161:303-15. 10.1111\/bjh.12236","journal-title":"Br J Haematol"},{"key":"ref12","article-title":"Castleman disease in the 21st century: an update on diagnosis, assessment, and therapy","volume":"8","author":"van Rhee F","year":"2010","unstructured":"van Rhee F, Stone K, Szmania S, Barlogie B, Singh Z. Castleman disease in the 21st century: an update on diagnosis, assessment, and therapy. Clin Adv Hematol Oncol. 2010, 8:486-98.","journal-title":"Clin Adv Hematol Oncol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s11899-017-0367-0","article-title":"POEMS syndrome: an Enigma","volume":"12","author":"Warsame R","year":"2017","unstructured":"Warsame R, Yanamandra U, Kapoor P. POEMS syndrome: an Enigma. Curr Hematol Malig Rep. 2017, 12:85-95. 10.1007\/s11899-017-0367-0","journal-title":"Curr Hematol Malig Rep"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24356","article-title":"Long-term outcome of patients with POEMS syndrome: an update of the Mayo Clinic experience","volume":"91","author":"Kourelis TV","year":"2016","unstructured":"Kourelis TV, Buadi FK, Kumar SK, et al.. Long-term outcome of patients with POEMS syndrome: an update of the Mayo Clinic experience. Am J Hematol. 2016, 91:585-9. 10.1002\/ajh.24356","journal-title":"Am J Hematol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2018.01.026","article-title":"Efficacy and long-term outcomes of autologous stem cell transplantation in POEMS syndrome: a nationwide survey in Japan","volume":"24","author":"Kawajiri-Manako C","year":"2018","unstructured":"Kawajiri-Manako C, Sakaida E, Ohwada C, et al.. Efficacy and long-term outcomes of autologous stem cell transplantation in POEMS syndrome: a nationwide survey in Japan. Biol Blood Marrow Transplant. 2018, 24:1180-6. 10.1016\/j.bbmt.2018.01.026","journal-title":"Biol Blood Marrow Transplant"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-12-328112","article-title":"Combination of melphalan and dexamethasone for patients with newly diagnosed POEMS syndrome","volume":"117","author":"Li J","year":"2011","unstructured":"Li J, Zhang W, Jiao L, et al.. Combination of melphalan and dexamethasone for patients with newly diagnosed POEMS syndrome. Blood. 2011, 117:6445-9. 10.1182\/blood-2010-12-328112","journal-title":"Blood"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25100","article-title":"A prospective phase II study of low dose lenalidomide plus dexamethasone in patients with newly diagnosed polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) syndrome","volume":"93","author":"Li J","year":"2018","unstructured":"Li J, Huang XF, Cai QQ, et al.. A prospective phase II study of low dose lenalidomide plus dexamethasone in patients with newly diagnosed polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) syndrome. Am J Hematol. 2018, 93:803-9. 10.1002\/ajh.25100","journal-title":"Am J Hematol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-019-0391-2","article-title":"What is the best first-line treatment for POEMS syndrome: autologous transplantation, melphalan and dexamethasone, or lenalidomide and dexamethasone?","volume":"33","author":"Zhao H","year":"2019","unstructured":"Zhao H, Huang XF, Gao XM, et al.. What is the best first-line treatment for POEMS syndrome: autologous transplantation, melphalan and dexamethasone, or lenalidomide and dexamethasone?. Leukemia. 2019, 33:1023-9. 10.1038\/s41375-019-0391-2","journal-title":"Leukemia"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(16)30157-0","article-title":"Safety and efficacy of thalidomide in patients with POEMS syndrome: a multicentre, randomised, double-blind, placebo-controlled trial","volume":"15","author":"Misawa S","year":"2016","unstructured":"Misawa S, Sato Y, Katayama K, et al.. Safety and efficacy of thalidomide in patients with POEMS syndrome: a multicentre, randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2016, 15:1129-37. 10.1016\/S1474-4422(16)30157-0","journal-title":"Lancet Neurol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-021-04609-6","article-title":"Bortezomib plus dexamethasone as first-line therapy for patients with POEMS syndrome","volume":"100","author":"Gao XM","year":"2021","unstructured":"Gao XM, Yu YY, Zhao H, et al.. Bortezomib plus dexamethasone as first-line therapy for patients with POEMS syndrome. Ann Hematol. 2021, 100:2755-61. 10.1007\/s00277-021-04609-6","journal-title":"Ann Hematol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.2009.01341.x","article-title":"Bortezomib: a new therapeutic option for POEMS syndrome","volume":"84","author":"Kaygusuz I","year":"2010","unstructured":"Kaygusuz I, Tezcan H, Cetiner M, Kocakaya O, Uzay A, Bayik M. Bortezomib: a new therapeutic option for POEMS syndrome. Eur J Haematol. 2010, 84:175-7. 10.1111\/j.1600-0609.2009.01341.x","journal-title":"Eur J Haematol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.2009.01330.x","article-title":"Successful bortezomib-based treatment in POEMS syndrome","volume":"83","author":"Tang X","year":"2009","unstructured":"Tang X, Shi X, Sun A, et al.. Successful bortezomib-based treatment in POEMS syndrome. Eur J Haematol. 2009, 83:609-10. 10.1111\/j.1600-0609.2009.01330.x","journal-title":"Eur J Haematol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1159\/000343681","article-title":"Effective induction therapy with subcutaneous administration of bortezomib for newly diagnosed POEMS syndrome: a case report and a review of the literature","volume":"129","author":"Zeng K","year":"2013","unstructured":"Zeng K, Yang JR, Li J, Wei Q, Yang YM, Liu T, Niu T. Effective induction therapy with subcutaneous administration of bortezomib for newly diagnosed POEMS syndrome: a case report and a review of the literature. Acta Haematol. 2013, 129:101-5. 10.1159\/000343681","journal-title":"Acta Haematol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2007.07.004","article-title":"POEMS syndrome","volume":"21","author":"Dispenzieri A","year":"2007","unstructured":"Dispenzieri A. POEMS syndrome. Blood Rev. 2007, 21:285-99. 10.1016\/j.blre.2007.07.004","journal-title":"Blood Rev"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2016.168","article-title":"Prognostic study for overall survival in patients with newly diagnosed POEMS syndrome","volume":"31","author":"Wang C","year":"2017","unstructured":"Wang C, Huang XF, Cai QQ, et al.. Prognostic study for overall survival in patients with newly diagnosed POEMS syndrome. Leukemia. 2017, 31:100-6. 10.1038\/leu.2016.168","journal-title":"Leukemia"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/102095-poems-syndrome-a-case-report-and-review-of-the-literature","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:38:49Z","timestamp":1707507529000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/102095-poems-syndrome-a-case-report-and-review-of-the-literature"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,19]]},"references-count":25,"URL":"https:\/\/doi.org\/10.7759\/cureus.27001","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7,19]]}}}